Randomized, Double-Blind, Placebo Controlled Trial of Low-Dose Pulse Methotrexate in Psoriatic Arthritis
β Scribed by Robert F. Willkens; H. James Williams; John R. Ward; Marlene J. Egger; James C. Reading; Philip J. Clements; Edgar S. Cathcart; Cecil O. Samuelson Jr; Marilyn A. Solsky; Stanley B. Kaplan; Maria Guttadauria; James T. Halla; Arthur Weinstein
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 598 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex
## Abstract ## Objective To evaluate the efficacy and safety of alefacept in combination with methotrexate (MTX) for the treatment of psoriatic arthritis (PsA). ## Methods Patients were eligible for this randomized, doubleβblind, placeboβcontrolled trial if they were ages 18β70 years and had act